Vita Reed covers healthcare, including health insurance, hospitals, medical devices and drug companies for the Orange County Business Journal. She can be reached at email@example.com.
Children’s Hospital of Orange County said today it's building a new children’s mental health inpatient center as part of an initiative that will be supported by a $5 million gift from Sandy Segerstrom Daniels.
Irvine-based Edwards Lifesciences Corp. said today that it is voluntarily halting enrollment in an early clinical trial for an experimental, less-invasive mitral heart valve.
Irvine-based Biolase Inc. said today that Harold Flynn Jr. will become its new chief executive, effective July 13.
Irvine-based Masimo Corp. said today that a federal court in Delaware has upheld a $467 million jury verdict in its favor against a pair of Netherlands-based Royal Philips Electronics NV's units for patent infringement.
HEALTHCARE: Glaukos aims for $86.3M, NYSE listing
Laguna Hills-based eye device startup Glaukos Corp. plans to use proceeds from a proposed initial offering to hire more workers, expand marketing programs, and fund further clinical studies.
Monitors Gain, Rainbow Product Line ‘Promising’
Masimo Corp. Chief Executive Joe Kiani says he’s “encouraged by our progress to date” as his company moves into the last 1 ½ years of a 10-year plan it established when it went public in 2007.
Laguna Hills-based Glaukos Corp. has filed plans to raise $86 million in an initial public offering.
HEALTHCARE: Actavis indicates new unit will offset chunk of layoffs
The makeover of Allergan Inc.’s operations in Irvine continues, with 1,100 jobs expected to be trimmed by next month.
HEALTHCARE: CHOC boss cites Innovation Institute as latest example
You’ll find Kimberly Chavalas Cripe among this year’s OC 50, the Business Journal’s annual inventory of the most influential members of the community of business here, and the subject of this week’s Special Report (see pullout for profiles).
Irvine-based Alphaeon Corp. named former Securities and Exchange Commissioner Christopher Cox and Silicon Valley executive Dennis Wolf to its board of directors.